Partnering with leading pharmaceutical companies is a key component of our business strategy. Based on our versatile vaccines’ platform and expertise in immunological sciences we seek

• to be a prime innovator for the pharmaceutical industry by contributing novel therapeutic vaccines addressing unmet medical needs.
• to selectively partner Immunodrug™ candidates addressing mass markets with the pharmaceutical industry after clinical proof-of-concept in phase II clinical trials.
• to provide pharmaceutical partners with access to our Immunodrug™ technology in well defined, target-specific licensing arrangements outside the scope of our own R & D programs.
• to benefit from potential cross-sector opportunities by applying Immunodrugs™ in human and animal health.

Cytos Biotechnology has successfully established partnerships with leading pharmaceutical companies.